Recent studies revealed that CDH1 and PIK3CA mutation in genetically modified mice could result in an immune-related subtype for invasive lobular carcinoma of the breast, which was characterized by enhanced immune infiltration and a strong signature for Treg cells and immunosuppressive molecule-based immune checkpoint activation (An et al., 2018). This evidence concerns the gene CDH1 and invasive lobular breast carcinoma.